In the ongoing battle against antibiotic resistance, a new study published in Engineering by Zhuoren Ling's research team unveils a promising triple combination of antibiotics that significantly expands our arsenal against drug-resistant bacteria. Titled "The Triple Combination of Meropenem, Avibactam, and a Metallo-β-Lactamase Inhibitor Optimizes Antibacterial Coverage Against Different β-Lactamase Producers," the research sheds light on a novel approach to tackle one of the most pressing global health challenges of our time.